# PREGABALIN
> **ANDA215675** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2022-09-14
## Drug
- **FDA Application Number:** ANDA215675
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PREGABALIN
- **Generic name:** PREGABALIN
- **Active ingredients:** PREGABALIN
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** ScieGen Pharmaceuticals, INC.
- **First approval:** 2022-09-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215675)
---
*AI Analytics · CC0 1.0*